Prevalence of and Clinical Outcome of Off-label Gabapentin Prescription in Orofacial Pain

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20230421003

Enrollment

100

Registered

2023-04-21

Start date

2023-02-22

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Orofacial pain patients orofacial pain gabapentin off-label

Interventions

Patients with orofacial pain at Faculty of Dentistry, Prince of Songkla University by determining prevalence of off-label gabapentin use, and assessing the clinical outcome

Other

Patients with orofacial pain

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All patients who were prescribed with gabapentin at Dental clinics, Faculty of Dentistry, PSU.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Prevalence of off-label use at beginning of study to at last visit of study Nominal	—

Secondary

Measure	Time frame
Clinical outcome First visit minus Last visit evaluation (NRS pain) Numeric	—

Countries

Thailand

Contacts

Public ContactJirayu Saepoo

Prince of Songkla University

jirayu.sa@psu.ac.th074287715

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026